SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K was filed on January 5, 2021, by Ra Medical Systems, Inc. (not Catheter Precision, Inc., as noted in the metadata request). The registrant is a Delaware corporation with principal executive offices in Carlsbad, California. The filing serves as a Regulation FD disclosure regarding an upcoming investor conference.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements or performance data.
Material Changes
No material changes to financial position or operations are reported in this document. The filing solely announces a scheduled corporate presentation.
Guidance, Outlook, and Management Commentary
- Event: Management will participate in the H.C. Wainwright Conference from January 11-14, 2021.
- Disclosure: A slide presentation (Exhibit 99.1) was attached to the filing and is available on the company's investor relations website.
- Legal Status: The information in this report and the attached presentation is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the company name is Ra Medical Systems, Inc. (RMED), not Catheter Precision, Inc.
- Review the attached Exhibit 99.1 (Corporate Presentation dated January 5, 2021) for specific business updates or forward-looking statements.
- Confirm the date and details of the H.C. Wainwright Conference participation (January 11-14, 2021).
- Note that this 8-K contains no audited financial data; refer to the most recent 10-K or 10-Q for financial metrics.